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Introduction. Maintaining quality of life is an important parameter during treatment. Pain is 
defined as an emotional, unpleasant experience, associated with present or potential tissue 
lesion. Pain can be part of having cancer or can be due to cancer treatment and chronic pain 
may cause exacerbations. Chronic pain is caused often by late stage cancer and to reduce its 
intensity opioids are administered. Therefore, an understanding of the pharmacology of opioids 
are required for their safe and appropriate use. Long-term opioid pharmacotherapy is associated 
with many adverse effects.   
Aim of the study.1. Identifying patients using opioid analgesic; 2. Patients observation during 
the entire period of treatment; 3. Adverse effects detection, timing when adverse reaction 
occurs and measures to be taken to avoid specific adverse reactions.   
Materials and methods. After inclusion and exclusion criteria were applied, 100 patients from 
Public Medical Sanitary Institution Institute of Oncology from Chisinau were selected for the 
study. Patients were randomized in two groups: first group (n=63 ) -patients receiving opioid 
analgesic during 14-35 days. Second group (n=37) –patients receiving opioids less then 14 
days. Patients were administered following drugs: trimeperidine (promedol) 2% -1ml, 
omnopon 1% -1ml, morphine 1% - 1ml and tramadol 5% -2ml. The study period was 02.2018 
- 02.2019, clinical effects were assessed by clinical examination and questionnaire. The data 
have been analyzed statistically using SPSS software.   
Results. Patients, receiving opioids from the first group experienced: constipation (89%), 
fatigue (60%), dyspepsia (16%), pruritus (8%), opioid withdrawal syndrome (agitation, 
tremors, insomnia, exacerbation of pain, neurovegetative symptoms) - 4%, and psychosis (2%). 
Patients from second group presented following side effects: constipation (12%), fatigue 
(7%).Early medication was initiated in order to prevent or to reduce adverse effects. Laxatives 
were administered for constipation, magnesium hydroxide was used if constipation was 
persistent. The dose of drug was reduced to decrease fatigue and drug was administered more 
frequently, lowering peak plasma-concentration. Also opioid drug changing was applied or 
non-opioid analgesics was included, in order to allow opioid dose reduction. Antiemetics have 
been administered to prevent or treat sensation of nausea and vomiting. Antihistamines was 
prescribed for pruritus. Doses have been reduced gradually to prevent opioid withdrawal. 
Antipsychotics have been administered in psychosis.   
Conclusions. Chronic pain can be managed and opioids adverse effects must be anticipated 
and treated.   
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